Login to Your Account



First H7N9 Avian Flu Vaccines Shown Effective in Trials

By John Fox
Contributing Writer

Wednesday, November 20, 2013

HONG KONG – Two new candidate vaccines against the virulent A(H7N9) avian influenza virus currently circulating in eastern China have been shown capable of inducing immunity in 80 percent to 85 percent of recipients, data from the first two Phase I trials suggest.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription